Vaksin Covid-19 Janssen: Perbedaan antara revisi

Konten dihapus Konten ditambahkan
Glorious Engine (bicara | kontrib)
←Membuat halaman berisi '{{Infobox drug | Verifiedfields = | verifiedrevid = | drug_name = | INN = | type = vaccine | image = Jo...'
 
k top: clean up
 
(6 revisi perantara oleh 4 pengguna tidak ditampilkan)
Baris 40:
| legal_UK_comment =
| legal_US = Tak disepakati
| legal_US_comment = ([[Otorisasi Pemakaian Darurat]])<ref name="Janssen COVID-19 Vaccine FDA PR 20210227label">{{cite press releaseweb | title=FDA Issues Emergency Use Authorization for ThirdJanssen COVID-19 Vaccine- | website=Uad26.Scov2.s [[Foodinjection, and Drug Administration]] (FDA)suspension | datewebsite=27 February 2021DailyMed | url=https://wwwdailymed.fdanlm.nih.gov/news-eventsdailymed/pressdrugInfo.cfm?setid=14a822ff-announcements/fdaf353-issues49f9-emergency-use-authorization-third-covida7f2-19-vaccine21424b201e3b | access-date=27 February 2021}}</ref><ref name="Janssen COVID-19 Vaccine FDA labelPR 20210227">{{cite webpress release | title=JanssenFDA Issues Emergency Use Authorization for Third COVID-19 Vaccine- ad26| website=U.cov2S.s injection,[[Food suspensionand Drug Administration]] (FDA) | websitedate=DailyMed27 February 2021 | url=https://dailymedwww.nlm.nihfda.gov/dailymednews-events/drugInfo.cfm?setid=14a822ffpress-f353announcements/fda-49f9issues-a7f2emergency-21424b201e3buse-authorization-third-covid-19-vaccine | access-date=27 February 2021}}</ref><ref name="FDA EUA">https://www.fda.gov/media/146303/download</ref>
| legal_EU = Otorisasi pemasaran kondisional diberikan
| legal_EU_comment = <ref name="COVID-19 Vaccine Janssen EPAR">{{cite web | title=COVID-19 Vaccine Janssen EPAR | website=[[European Medicines Agency]] (EMA) | date=5 March 2021 | url=https://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-janssen | access-date=16 March 2021}}</ref>
Baris 69:
 
<!-- Chemical and physical data -->}}
{{COVID-19 pandemic sidebar|expanded=medis}}
 
'''Vaksin COVID-19 Johnson & Johnson''' adalah [[vaksin COVID-19]] [[vektor viral]] [[Adenoviridae|adenovirus]] manusia<ref name="ensemble" /> yang dikembangkan oleh [[Janssen Vaccines]] di [[Leiden]], Belanda,<ref>{{Cite web|url=https://nltimes.nl/2021/02/16/leiden-developed-covid-19-vaccine-submitted-ema-approval|title=Leiden developed Covid-19 vaccine submitted to EMA for approval|date=2021-02-16}}</ref> dan perusahaan induknya di Belgia [[Janssen Pharmaceuticals]],<ref>{{Cite web|title=Clinical trial COVID-19 vaccine candidate underway|url=https://www.janssen.com/belgium/clinical-trial-covid-19-vaccine-candidate-underway|access-date=2021-03-13|website=Janssen Belgium|language=en}}</ref> subsidier dari perusahaan Amerika Serikat [[Johnson & Johnson]] (J&J).<ref>{{Cite web|url=https://nltimes.nl/2021/03/11/ema-recommends-johnson-johnson-covid-vaccine-approval-developed-leiden|title=EMA recommends Johnson & Johnson Covid vaccine for approval; Developed in Leiden|publisher=NL Times}}</ref><ref name="Globe 20200312">{{cite news|url=https://www.bostonglobe.com/2020/03/12/business/beth-israel-is-working-with-johnson-johnson-coronavirus-vaccine/|title=Beth Israel is working with Johnson & Johnson on a coronavirus vaccine|work=The Boston Globe|date=12 March 2020|first=Jonathan |last=Saltzman | name-list-style=vanc}}</ref>
 
Vaksin tersebut berbahan dasar adenovirus manusia yang dimodifikasi untuk membuat gen untuk menciptakan [[spike protein]] terhadap virus [[SARS-CoV-2]] yang menyebabkan COVID-19.<ref name="Janssen CMA application" /> Vaksin tersebut hanya diwajibkan satu dosis dan tak perlu disimpan beku.<ref name="Fact sheet" />
Baris 89:
{{COVID-19}}
 
[[CategoryKategori:Adenoviridae]]
[[CategoryKategori:Janssen Pharmaceutica]]
[[Category:vaksin COVID-19]]
[[CategoryKategori:Johnson & Johnson]]
[[Category:Janssen Pharmaceutica]]
[[Kategori:Vaksin Covid-19]]
[[Category:Johnson & Johnson]]